Lantern Pharma Inc. Proceeds from Loans
Lantern Pharma Inc. (LTRN) reported Proceeds from Loans of $108.50 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-10-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLoans · last filed 2023-03-20
- 2020-09-30: Proceeds from Loans 9 month $108.50K.
- 2020-05-01: Proceeds from Loans 0 month $108.50K.
| Period end | Proceeds from Loans 0 month | Proceeds from Loans 9 month |
|---|---|---|
| 2020-09-30 | $108.50K 10-Q · filed 2020-10-29 | |
| 2020-05-01 | $108.50K 10-K · filed 2023-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |